News & Updates

Show Multimedia Only

Product Highlight - SCATUBEX

31 Aug 2023

Allium cepa 12% topical gel

Product Highlight - SCATUBEX

31 Aug 2023

Product Highlight - TROPICEE BOOSTER

31 Aug 2023

Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3) capsule 500 mg/ 10 mg/ 1,000 IU

Product Highlight - TROPICEE BOOSTER

31 Aug 2023

Product Highlight - IVCORT

31 Aug 2023

Hydrocortisone Na succinate 100 mg powd for inj

Product Highlight - IVCORT

31 Aug 2023

Product Highlight - VARICURE

31 Aug 2023

Diosmin + hesperidin 450 mg/50 mg FC tab

Product Highlight - VARICURE

31 Aug 2023

Product Highlight - NASATAPP NO-DROWSE

31 Aug 2023

Paracetamol + phenylephrine HCl tab 500 mg/25 mg

Product Highlight - NASATAPP NO-DROWSE

31 Aug 2023

Jakinibs for AD in Asians: Is one better than the other?

31 Aug 2023 by

Treatment with oral Janus kinase (JAK) inhibitors or jakinibs appeared well tolerated in patients with atopic dermatitis (AD) as shown in an Asian retrospective cohort study.

Jakinibs for AD in Asians: Is one better than the other?

31 Aug 2023

Product Highlight - FOLIDYN

31 Aug 2023

Folic acid cap 5 mg

Product Highlight - FOLIDYN

31 Aug 2023

Product Highlight - KANJINTI

31 Aug 2023

Trastuzumab Powd for conc for soln for infusion 150 mg

Product Highlight - KANJINTI

31 Aug 2023

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

31 Aug 2023

Paracetamol + Orphenadrine Citrate 450 mg/35 mg FC tab and 650 mg/35 mg FC tab (Forte)

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

31 Aug 2023

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

30 Aug 2023 by

Treatment with nirmatrelvir plus ritonavir appears to reduce the incidence of hospitalization in a highly vaccinated population of high-risk COVID-19 patients in Malaysia, as shown in a study.

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

30 Aug 2023

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Product Highlight - SCATUBEX

Product Highlight - SCATUBEX

Product Highlight - TROPICEE BOOSTER

Product Highlight - TROPICEE BOOSTER

Product Highlight - IVCORT

Product Highlight - IVCORT

Product Highlight - VARICURE

Product Highlight - VARICURE

Product Highlight - NASATAPP NO-DROWSE

Product Highlight - NASATAPP NO-DROWSE

Jakinibs for AD in Asians: Is one better than the other?

Jakinibs for AD in Asians: Is one better than the other?

Product Highlight - FOLIDYN

Product Highlight - FOLIDYN

Product Highlight - KANJINTI

Product Highlight - KANJINTI

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

Product Highlight - NORPRIEXIA/NORPRIEXIA FORTE

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients

Nirmatrelvir–ritonavir combo averts hospitalization in high-risk COVID patients